Published in Adv Exp Med Biol on January 01, 1985
Photodynamic therapy. J Natl Cancer Inst (1998) 12.83
Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature (1983) 11.57
Structural evidence for the authenticity of the human retinoblastoma gene. Science (1987) 4.67
Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res (1976) 4.60
Gene for hereditary retinoblastoma assigned to human chromosome 13 by linkage to esterase D. Science (1983) 4.43
Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science (1989) 3.63
Retinoblastoma: clues to human oncogenesis. Science (1984) 3.43
Expression and amplification of the N-myc gene in primary retinoblastoma. Nature (1984) 2.99
Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science (1988) 2.83
Patient with 13 chromosome deletion: evidence that the retinoblastoma gene is a recessive cancer gene. Science (1983) 2.78
Regional assignment of genes for human esterase D and retinoblastoma to chromosome band 13q14. Science (1980) 2.72
Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res (1979) 2.51
Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol (1996) 1.95
Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines. Cancer Res (2001) 1.44
Putative non-Mendelian transmission of retinoblastoma in males: a phenotypic segregation analysis of 150 pedigrees. Hum Genet (1994) 1.43
Relationship between misonidazole toxicity and core temperature in C3H mice. Radiat Res (1979) 1.32
Glucose regulated protein induction and cellular resistance to oxidative stress mediated by porphyrin photosensitization. Cancer Res (1991) 1.30
Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteins. Cancer Res (1996) 1.28
Establishment of a Chinese hamster ovary cell line that expresses grp78 antisense transcripts and suppresses A23187 induction of both GRP78 and GRP94. J Cell Physiol (1992) 1.27
Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res (2000) 1.26
Energetics and efficiency of photoinactivation of murine tumor cells containing hematoporphyrin. Cancer Res (1976) 1.22
Clinical and preclinical photodynamic therapy. Lasers Surg Med (1995) 1.22
Properties and applications of photodynamic therapy. Radiat Res (1989) 1.17
Immunohistochemistry and electron microscopy of choroidal infiltrates and Dalen-Fuchs nodules in sympathetic ophthalmia. Ophthalmology (1985) 1.15
Nonrandom chromosomal changes in untreated retinoblastomas. Cancer Genet Cytogenet (1983) 1.15
Iris mammillations: significance and associations. Eye (Lond) (1996) 1.11
Prediction of familial predisposition to retinoblastoma. N Engl J Med (1986) 1.08
Photoinactivation of Chinese hamster cells by hematoporphyrin derivative and red light. Photochem Photobiol (1980) 1.07
Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizer. Int J Radiat Oncol Biol Phys (1979) 1.06
Correlation between balance of specific chromosomes and expression of malignancy in hamster cells. J Natl Cancer Inst (1975) 1.05
Differential cell photosensitivity following porphyrin photodynamic therapy. Cancer Res (1988) 1.02
Photodynamic therapy mediated induction of early response genes. Cancer Res (1994) 1.01
Hypothalamic-pituitary function in children with optic nerve hypoplasia. Am J Dis Child (1985) 1.00
Dominant cone-rod dystrophy. Doc Ophthalmol (1975) 0.98
Comparison of mutagenicity and induction of sister chromatid exchange in Chinese hamster cells exposed to hematoporphyrin derivative photoradiation, ionizing radiation, or ultraviolet radiation. Cancer Res (1983) 0.98
The Rb gene suppresses the growth of normal cells. Oncogene (1993) 0.95
The gene responsible for the development of retinoblastoma and osteosarcoma. Cancer (1988) 0.95
Increased photosensitivity in HL60 cells expressing wild-type p53. Photochem Photobiol (1997) 0.95
Molecular, cellular, and tissue responses following photodynamic therapy. Lasers Surg Med (1988) 0.95
The nude mouse model for human retinoblastoma: a system for evaluation of retinoblastoma therapy. Med Pediatr Oncol (1980) 0.95
Systemic toxicity in mice induced by localized porphyrin photodynamic therapy. Cancer Res (1990) 0.94
Nuclear factor kappa B binding activity in mouse L1210 cells following photofrin II-mediated photosensitization. Photochem Photobiol (1993) 0.93
Increased transcription and translation of heme oxygenase in Chinese hamster fibroblasts following photodynamic stress or Photofrin II incubation. Photochem Photobiol (1991) 0.93
Microbial keratitis in children. Ophthalmology (1986) 0.92
Tumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma. Br J Ophthalmol (2003) 0.91
Acute skin response in albino mice following porphyrin photosensitization under oxic and anoxic conditions. Photochem Photobiol (1984) 0.90
Preferential retention of paternal alleles in human retinoblastoma: evidence for genomic imprinting. Cell Growth Differ (1990) 0.90
Cellular targets and molecular responses associated with photodynamic therapy. J Clin Laser Med Surg (1996) 0.90
Photodynamic therapy of intraocular tumors: examination of hematoporphyrin derivative distribution and long-term damage in rabbit ocular tissue. Cancer Res (1985) 0.89
Photodynamic therapy-mediated oxidative stress as a molecular switch for the temporal expression of genes ligated to the human heat shock promoter. Cancer Res (2000) 0.89
Decreased expression and function of alpha-2 macroglobulin receptor/low density lipoprotein receptor-related protein in photodynamic therapy-resistant mouse tumor cells. Cancer Res (1995) 0.89
Complete or partial homozygosity of chromosome 13 in primary retinoblastoma. Cancer Res (1987) 0.89
Tissue distribution of 3H-hematoporphyrin derivative in athymic "nude" mice heterotransplanted with human retinoblastoma. Invest Ophthalmol Vis Sci (1982) 0.89
Images of Lisch nodules across the spectrum. Eye (Lond) (1993) 0.88
The evolution of photodynamic therapy techniques in the treatment of intraocular tumors. Photochem Photobiol (1987) 0.87
Discovery of a regulatory motif that controls the exposure of specific upstream cyclin-dependent kinase sites that determine both conformation and growth suppressing activity of pRb. J Biol Chem (1999) 0.87
Differential photosensitivity in wild-type and mutant p53 human colon carcinoma cell lines. J Photochem Photobiol B (1998) 0.86
Photosensitization with derivatives of chlorin p6. J Photochem Photobiol B (1995) 0.85
Observations in studies of quantitative kinetics of tritium labelled hematoporphyrin derivatives (HpDI and HpDII) in the normal and neoplastic rat brain model. J Neurooncol (1984) 0.85
Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model. Cancer Res (1992) 0.84
The hypoxic cell sensitizer programme in the United States. Br J Cancer Suppl (1978) 0.84
Ocular findings in mannosidosis. Am J Ophthalmol (1976) 0.84
DNA damage and repair in CHO cells following hematoporphyrin photoradiation. Cancer Lett (1980) 0.84
The effect of localized porphyrin photodynamic therapy on the induction of tumour metastasis. Br J Cancer (1987) 0.83
Tumor regression of human retinoblastoma in the nude mouse following photoradiation therapy: a preliminary report. Med Pediatr Oncol (1980) 0.83
Hematoporphyrin derivative photoradiation induced damage to normal and tumor tissue of the pigmented rabbit eye. Curr Eye Res (1984) 0.83
Orbital development after enucleation in early childhood. Ophthal Plast Reconstr Surg (1999) 0.83
Ineffective photodynamic therapy (PDT) in a poorly vascularized xenograft model. Br J Cancer (1988) 0.82
Direct comparison of in-vitro and in-vivo Photofrin-II mediated photosensitization using a pulsed KTP pumped dye laser and a continuous wave argon ion pumped dye laser. Lasers Surg Med (1991) 0.81
Neonatal neuroblastoma metastatic to the iris. Cancer (1983) 0.81
Cataract in mannosidosis. Birth Defects Orig Artic Ser (1976) 0.81
Non-fastidious, melanoma-specific CD8+ cytotoxic T lymphocytes from choroidal melanoma patients. Cancer Immunol Immunother (1994) 0.81
Hematoporphyrin derivative photoradiation therapy for the treatment of intraocular tumors: examination of acute normal ocular tissue toxicity. Cancer Res (1983) 0.81
Porphyrin photosensitivity in cell lines expressing a heat-resistant phenotype. Cancer Res (1990) 0.80
Total hyphema evacuation by vitrectomy instrumentation. Ophthalmology (1981) 0.79
Pseudo low penetrance in retinoblastoma. Fortuitous familial aggregation of sporadic cases caused by independently derived mutations in two large pedigrees. Arch Ophthalmol (1993) 0.79
Expression of potentially lethal damage in Chinese hamster cells exposed to hematoporphyrin derivative photodynamic therapy. Cancer Res (1986) 0.79
Malignant transformation of mouse cells by cigarette smoke condensate. Cancer Res (1975) 0.78
Photodynamic therapy sensitivity is not altered in human tumor cells after abrogation of p53 function. Cancer Res (1999) 0.78
Adriamycin resistance in Chinese hamster fibroblasts following oxidative stress induced by photodynamic therapy. Photochem Photobiol (1993) 0.78
Episcleral plaque thermoradiotherapy of posterior uveal melanomas. Am J Clin Oncol (1996) 0.78